igf-1 lr3 side effects risks IGF-1, the Cross Road of
Description
Neurosci Biobehav Rev 114:134
288 : H13H21
Figure 5 Deferoxamine chelates iron and inhibits ACSL4, while rosmarinic acid activates Nrf2 by disrupting its Keap1 interaction
These modifications result in reduced binding to IGF binding proteins, leading to enhanced biological activity
